SCHEMBL367205

SCHEMBL367205

CN(C)C(=O)c1ccc2c(C(=O)O)c3ccccc3n2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.45
SRC P12931 3/20 0.45
KDM4E B2RXH2 3/20 0.41
AGTR1 P30556 5/20 0.40
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
MEN1 O00255 1/20 0.39
CYP2D6 P10635 1/20 0.39
KMT2A Q03164 1/20 0.39
HIF1A Q16665 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RARG P13631 1/20 0.39
POLB P06746 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
RORC P51449 1/20 0.38
USP2 O75604 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365250 0.85 NR4A2 (0.45) EGFRSRCKDM4EALDH1A1MEN1
SCHEMBL365935 0.85 KDM4E (0.47) EGFRSRCKDM4EAGTR1ALDH1A1
SCHEMBL366876 0.84 EGFR (0.44) EGFRSRCKDM4EAGTR1ALDH1A1
SCHEMBL366811 0.81 EGFR (0.44) EGFRSRCKDM4EAGTR1ALDH1A1
SCHEMBL366371 0.81 EGFR (0.45) EGFRSRCKDM4EAGTR1ALDH1A1
SCHEMBL365388 0.80 ALDH1A1 (0.49) EGFRSRCKDM4EALDH1A1HPGD
SCHEMBL366790 0.79 EGFR (0.41) EGFRSRCKDM4EAGTR1ALDH1A1
SCHEMBL367204 0.78 RORC (0.43) EGFRSRCKDM4EALDH1A1MEN1
SCHEMBL366536 0.78 EGFR (0.53) EGFRSRCKDM4EALDH1A1HPGD
SCHEMBL365912 0.78 CES1 (0.45) EGFRSRCKDM4EAGTR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed